Herein, caspase-4 could be identified as a novel oncoprotein since 79.3 and 88.2% of adenocarcinoma and squamous NSCLC patients, respectively, stained positive for the protein which pro-tumor activity was reflected in a concerted cooperation with mutated K-Ras and cMyC. Here, KRAS is linked to adenocarcinoma.